Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
22.52
Oct 23 • 3:59 PM ET Dollar change-0.17 Percentage change(-0.75%)
Aftermarket Close
22.35
Aftermarket • 7:30 PM ET Dollar change-0.17 Percentage change(-0.75%)
Oct 22, 6:55 AMElanco Animal Health names Jamie Preston EVP and Chief People Officer effective November 3, succeeding Dave Kinard, who will retire at year-end
Index
-
Market Cap
11.25B
Enterprise Value
14.64B
Income
-199.00M
Sales
5.02B
Book/sh
13.19
Cash/sh
1.06
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
9900
IPO
Sep 20, 2018
P/E
-
Forward P/E
17.61
PEG
1.14
P/S
2.24
P/B
1.71
P/C
21.23
P/FCF
29.69
EV/EBITDA
14.27
EV/Sales
2.92
Quick Ratio
1.10
Current Ratio
2.05
Debt/Eq
0.59
LT Debt/Eq
0.58
Option/Short
Yes / Yes
EPS (ttm)
-0.40
EPS next Y
1.28
EPS next Q
0.21
EPS this Y
21.13%
EPS next Y
12.33%
EPS next 5Y
15.39%
EPS past 3/5Y
-43.04% 18.11%
Sales past 3/5Y
2.25% 7.57%
EPS Y/Y TTM
-145.71%
Sales Y/Y TTM
11.95%
EPS Q/Q
380.63%
Sales Q/Q
10.23%
Insider Own
1.02%
Insider Trans
1.37%
Inst Own
115.10%
Inst Trans
4.23%
ROA
-1.46%
ROE
-2.98%
ROIC
-1.91%
Gross Margin
44.28%
Oper. Margin
6.63%
Profit Margin
-3.96%
SMA20
-0.51%
SMA50
-2.98%
SMA200
-5.44%
Trades
Shs Outstand
499.55M
Shs Float
494.51M
52W High
27.98 -19.51%
52W Low
19.40 16.08%
Volatility
3.26% 3.04%
ATR (14)
0.72
RSI (14)
45.55
Beta
1.74
Rel Volume
0.69
Avg Volume
6.24M
Volume
4,278,032
Perf Week
-4.37%
Perf Month
0.76%
Perf Quarter
-11.37%
Perf Half Y
-1.01%
Perf YTD
-0.49%
Perf Year
3.45%
Perf 3Y
147.47%
Perf 5Y
-33.57%
Perf 10Y
-
Prev Close
22.69
Price
22.52
Change %
-0.75%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bettington Timothy JSEE REMARKSOct 15 '26Sale23.004,350100,050138,911Oct 19 04:15 PM
Bettington Timothy JOfficerOct 15 '26Proposed Sale23.004,350100,050Oct 15 04:01 PM
Kurzius Lawrence ErikDirectorAug 20 '26Buy23.4040,000935,920188,647Aug 21 04:16 PM
O'Neill ShivGC AND CORP SECAug 18 '26Buy23.583,99894,27387,832Aug 18 04:32 PM
Harrington Michael JDirectorAug 12 '26Buy21.825,000109,100131,451Aug 13 04:28 PM
VanHimbergen Robert MEVP and CFOAug 07 '26Buy23.084,20096,926137,516Aug 10 04:14 PM
Herendeen PaulDirectorAug 07 '26Buy23.6810,000236,850111,687Aug 10 04:13 PM
Modi Rajeev A.SEE REMARKSMay 15 '26Buy20.354,91199,939160,812May 19 04:39 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORMay 15 '26Buy20.094,97199,843171,971May 19 04:38 PM
Kurzius Lawrence ErikDirectorDec 12 '25Buy21.3010,000213,000131,773Dec 16 04:42 PM
Modi Rajeev A.SEE REMARKSDec 11 '25Buy21.334,50095,985123,082Dec 15 04:43 PM
VanHimbergen Robert MEVP and CFODec 11 '25Buy21.646,950150,426124,233Dec 15 04:42 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORDec 11 '25Buy21.7522,000478,496167,000Dec 15 04:41 PM
Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Indianapolis, IN.
PresidentMr. Jeffrey N. Simmons
Executive VP & CFOMr. Robert M. VanHimbergen
Executive VP & President of Elanco InternationalDr. Ramiro Martin Cabral
Executive Vice President of ResearchDr. Ellen de Brabander Ph.D.
Executive Vice President of Center of Strategic GrowthMr. Timothy J. Bettington